These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 35586776)

  • 1. History in Perspective: The prime pathological players and role of phytochemicals in Alzheimer's disease.
    Sajad M; Kumar R; Thakur SC
    IBRO Neurosci Rep; 2022 Jun; 12():377-389. PubMed ID: 35586776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiology of Alzheimer's disease.
    Mohandas E; Rajmohan V; Raghunath B
    Indian J Psychiatry; 2009 Jan; 51(1):55-61. PubMed ID: 19742193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's Disease and Protein Kinases.
    Engin AB; Engin A
    Adv Exp Med Biol; 2021; 1275():285-321. PubMed ID: 33539020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.
    Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G
    Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Potential of Alkaloidal Phytochemicals Targeting Neuroinflammatory Signaling of Alzheimer's Disease.
    Uddin MS; Kabir MT; Al Mamun A; Behl T; Mansouri RA; Aloqbi AA; Perveen A; Hafeez A; Ashraf GM
    Curr Pharm Des; 2021; 27(3):357-366. PubMed ID: 32473620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of NF-κB and Wnt/β-catenin Signaling Pathways in Alzheimer's Disease and Potential Active Drug Treatments.
    Liu X; Wang K; Wei X; Xie T; Lv B; Zhou Q; Wang X
    Neurochem Res; 2021 Apr; 46(4):711-731. PubMed ID: 33523396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer's Disease.
    Marttinen M; Takalo M; Natunen T; Wittrahm R; Gabbouj S; Kemppainen S; Leinonen V; Tanila H; Haapasalo A; Hiltunen M
    Front Neurosci; 2018; 12():963. PubMed ID: 30618585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis.
    Bowirrat A
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer's Disease.
    Zhao Y; Liu B; Wang J; Xu L; Yu S; Fu J; Yan X; Su J
    Biomedicines; 2022 Jul; 10(8):. PubMed ID: 35892700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the Understanding of the Correlation Between Neuroinflammation and Microglia in Alzheimer's Disease.
    Yan H; Wang W; Cui T; Shao Y; Li M; Fang L; Feng L
    Immunotargets Ther; 2024; 13():287-304. PubMed ID: 38881647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer's Disease.
    Xu YJ; Au NPB; Ma CHE
    Front Aging Neurosci; 2022; 14():896852. PubMed ID: 35693341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tau protein in Alzheimer's disease: The prime pathological player.
    Muralidar S; Ambi SV; Sekaran S; Thirumalai D; Palaniappan B
    Int J Biol Macromol; 2020 Nov; 163():1599-1617. PubMed ID: 32784025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Target Mechanisms of Phytochemicals in Alzheimer's Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation.
    Sharifi-Rad J; Rapposelli S; Sestito S; Herrera-Bravo J; Arancibia-Diaz A; Salazar LA; Yeskaliyeva B; Beyatli A; Leyva-Gómez G; González-Contreras C; Gürer ES; Martorell M; Calina D
    J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology.
    Hossain MF; Uddin MS; Uddin GMS; Sumsuzzman DM; Islam MS; Barreto GE; Mathew B; Ashraf GM
    Mol Neurobiol; 2019 Dec; 56(12):8255-8276. PubMed ID: 31209782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Friend, Foe or Both? Immune Activity in Alzheimer's Disease.
    Frost GR; Jonas LA; Li YM
    Front Aging Neurosci; 2019; 11():337. PubMed ID: 31920620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.